Syphilis
Clinical Snapshot
Syphilis is caused by Treponema pallidum, a bacterium that penetrates broken skin or mucous membranes, almost always through sexual contact. Canadian syphilis rates have risen sharply enough that screening recommendations were formally updated in 2024 — screening is now recommended for every sexually active person with a new or multiple partners, or on patient request, with repeat screening every 3-6 months for anyone with ongoing multiple partners.[1] Benzathine penicillin G is the only consistently effective treatment at every stage — there is no equally effective non-penicillin alternative, which makes penicillin allergy a genuine management problem rather than a simple substitution.[2]
Recognize the Condition
Staging Determines Everything
Syphilis is staged by clinical presentation and known or estimated duration — the stage determines the entire treatment plan.
Primary syphilis
A chancre: classically a single, large, painless genital ulcer. Genital herpes ulcers, by contrast, are typically multiple, small, painful, and vesiculoulcerative — but there is real overlap in presentation, so do not rule out syphilis just because an ulcer looks atypical.
Secondary syphilis
A systemic stage: rash (classically involving the palms and soles), lymphadenopathy, and sometimes serious end-organ involvement including ocular syphilis or neurosyphilis. Both primary and secondary syphilis can present with ulcerative lesions.
Early latent syphilis
Asymptomatic infection of under 1 year's duration, confirmed serologically.
Late latent syphilis / unknown duration
Asymptomatic infection of over 1 year's duration, or duration that cannot be established.
Tertiary and neurosyphilis
Cardiovascular syphilis, gummatous disease, and neurosyphilis (which can occur at any stage, not only late disease). Ocular syphilis and neurosyphilis, especially with acute presentation, need urgent specialist consultation.
Risk Factors
- New sexual partner or multiple sexual partners — this is now itself sufficient to recommend syphilis screening, independent of symptoms.[1]
- A partner with confirmed or suspected syphilis.
- Men who have sex with men, and other populations with higher background prevalence.
- Pregnancy — universal screening is recommended, given the severity of untreated congenital syphilis.
- Other genital-ulcer STIs increase the risk of acquiring and transmitting HIV — consider HIV testing alongside syphilis testing.
Red Flags & Refer
Refer for any of the following:
- Suspected ocular syphilis or neurosyphilis, especially with an acute presentation — needs specialist consultation, not routine outpatient management.
- Suspected or confirmed tertiary syphilis.
- Penicillin required (pregnancy, neurosyphilis) but the patient has a genuine penicillin allergy — refer for specialist-directed penicillin desensitization.
Assessment & Diagnosis
Direct detection
Swab an anogenital or oral lesion for PCR where available; darkfield microscopy or direct immunofluorescence antibody testing on lesion fluid is an option where available for anogenital lesions specifically.
Serology
Serologic testing is the mainstay for staging and follow-up: a nontreponemal test (used for initial screening and for monitoring treatment response by titre) is paired with a treponemal test (used to confirm the diagnosis, and which typically remains positive for life even after successful treatment). Use your laboratory's specific testing algorithm and sequence, and interpret results in the context of prior treatment history when known.[2]
Treatment Targets
- Cure the infection with an effective penicillin regimen matched to the correct stage.
- Prevent progression to tertiary disease, neurosyphilis, or ocular syphilis.
- Prevent transmission to sexual partners.
- Prevent vertical transmission and congenital syphilis when the patient is pregnant.
Choose Initial Treatment
Primary, secondary, or early latent syphilis (under 1 year's duration): benzathine penicillin G 2.4 million units IM as a single dose (consider a second dose 1 week later if the patient is pregnant).
Late latent syphilis, syphilis of unknown duration, cardiovascular syphilis, or tertiary syphilis not involving the CNS: benzathine penicillin G 2.4 million units IM weekly for 3 doses.
Neurosyphilis (any stage): benzylpenicillin (aqueous penicillin G) 3-4 million units IV every 4 hours (16-24 million units/day) for 10-14 days — a different drug and route from the other stages; do not substitute benzathine penicillin, which does not achieve adequate CNS penetration.[2]
Do not confuse: benzathine penicillin G (long-acting IM) with benzylpenicillin/aqueous penicillin G (short-acting IV) — they are used for different stages and are not interchangeable.
Azithromycin is not recommended for syphilis — treatment failures and resistance have been reported.[3]
Non-Pharmacologic Treatment
- Test and treat all sexual contacts within the relevant trace-back window (see Special Populations and Drug Tables).
- Advise abstaining from sexual contact until the patient and any recently treated partner(s) have completed treatment.
- Counsel specifically on the Jarisch-Herxheimer reaction (see Monitoring) before treatment, so the patient is not alarmed if it occurs.
Special Populations
Partner trace-back windows
| Diagnosis | Trace-back period | Action |
|---|---|---|
| Primary syphilis | 3 months | Refer all partners for testing; refer all partners within the previous 3 months for empiric treatment even if their test is negative. |
| Secondary syphilis | 6 months | Same approach — test all partners; empirically treat partners within the trace-back window even if seronegative. |
| Early latent syphilis | 1 year | Same approach, extended to a 1-year window. |
| Late latent syphilis | Not time-limited | Test all long-term partners, and any of their children who may have been exposed during pregnancy. |
Monitoring & Follow-Up
- Follow every treated patient serologically (nontreponemal titres) to confirm an adequate treatment response and to detect possible treatment failure.
- Counsel patients about the Jarisch-Herxheimer reaction before treatment: fever, chills, rigors, and sweating that can occur at any stage but is most common in early syphilis, resolving within 24 hours. This is not a drug allergy and does not mean penicillin should be avoided in future.
- Refer for ongoing follow-up of a newborn whose parent was treated less than 4 weeks before delivery, to exclude congenital syphilis.
Common Errors to Avoid
- Confusing benzathine penicillin G (long-acting IM, used for primary/secondary/latent/cardiovascular/tertiary non-CNS disease) with benzylpenicillin/aqueous penicillin G (short-acting IV, used for neurosyphilis) — these are not interchangeable.
- Treating the Jarisch-Herxheimer reaction as a penicillin allergy and avoiding penicillin in the future as a result.
- Using azithromycin for syphilis — it is no longer recommended.
- Substituting doxycycline or ceftriaxone for penicillin in a pregnant patient instead of arranging desensitization.
- Treating a genital ulcer as herpes without adequately considering syphilis, given the real overlap in how the two can present.
Clinical Decision Algorithm
Drug Tables
How to use this table: Doses are adult doses and require patient-specific confirmation. Test and treat sexual contacts within the stage-specific window. Select any drug name to open its complete Pharmasist Drug Database page.
Penicillins — Preferred at Every Stage
Benzathine penicillin G and benzylpenicillin (aqueous penicillin G) are different formulations used for different stages — do not interchange them.
| Drug | Dosage | Adverse effects | Comments |
|---|---|---|---|
| Benzathine penicillin G — primary/secondary/early latent Bicillin L-A | 2.4 million units IM as a single dose (consider a 2nd dose 1 week later if the patient is pregnant). | Jarisch-Herxheimer reaction (fever, chills, rigors, sweating, resolving within 24 hours) — not a drug allergy. | Supplied as 2 mL prefilled syringes containing 1.2 million units each — 2 injections are needed to give the full single dose. Do not confuse with benzylpenicillin. Tetracyclines may decrease penicillin efficacy — avoid combining. |
| Benzathine penicillin G — late latent/unknown duration/cardiovascular/tertiary non-CNS Bicillin L-A | 2.4 million units IM weekly x 3 doses. | Jarisch-Herxheimer reaction, as above. | Consider penicillin desensitization in a penicillin-allergic patient rather than defaulting to doxycycline, particularly at this stage. |
| Benzylpenicillin (aqueous penicillin G) — neurosyphilis generics | 3-4 million units IV every 4 hours (16-24 million units/day) x 10-14 days. | Jarisch-Herxheimer reaction, as above. | The preferred regimen specifically for neurosyphilis — benzathine penicillin does not achieve adequate CNS levels. Can be used in pregnancy and breastfeeding. |
Cephalosporins — Last-Resort Alternative
Use only in exceptional circumstances, generally alongside desensitization planning.
| Drug | Dosage | Adverse effects | Comments |
|---|---|---|---|
| Ceftriaxone generics | All stages except neurosyphilis: 1 g IV/IM daily x 10 days. Neurosyphilis: 2 g IV/IM daily x 10-14 days. | GI upset, hypersensitivity reactions. | Last-resort alternative, including for patients undergoing penicillin desensitization. Not a satisfactory alternative to penicillin in pregnancy. Do not reconstitute or co-administer with calcium-containing IV solutions. |
Tetracyclines — Alternative for Non-Neurosyphilis, Non-Pregnant Patients
Contraindicated in pregnancy and breastfeeding — not an option in that population.
| Drug | Dosage | Adverse effects | Comments |
|---|---|---|---|
| Doxycycline — primary/secondary/early latent generics | 100 mg PO BID x 14 days. | GI upset, rash, candidal vaginitis, photosensitivity. | Useful for a genuinely penicillin-allergic patient who is not pregnant and does not have neurosyphilis. Decreased levels with antacids, iron, bismuth, carbamazepine, phenytoin. May decrease penicillin efficacy if combined. |
| Doxycycline — late latent/unknown duration/cardiovascular/tertiary non-CNS generics | 100 mg PO BID x 28 days. | Same as above. | Consider penicillin desensitization first, even in a penicillin-allergic patient, given the stakes of undertreating this stage. |
Not recommended: azithromycin is not recommended for syphilis at any stage — treatment failures and resistance have been reported.
Evidence note: Drug inventory, dosing, adverse effects, and comments reflect standard Canadian practice per current PHAC guidance.[2]
References
- Recommendations on screening for syphilis in non-pregnant adults and adolescents — Canada Communicable Disease Report (National Advisory Committee on Sexually Transmitted and Blood-Borne Infections). CCDR 2024;50(7/8)
- Syphilis guide: Key information and resources — Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections
- Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis — New England Journal of Medicine (Riedner G, Rusizoka M, Todd J, et al.). N Engl J Med 2005;353(12):1236-1244
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.